Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 94428 · Class III · Oklahoma Blood Institute
Key facts
| Event ID | 94428 |
|---|---|
| Recall numbers | B-0277-2024 |
| Recalling firm | Oklahoma Blood Institute |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Apheresis Platelets, shipped with a temperature that was unacceptable, were distributed. |
| Initiation date | Feb 14, 2024 |
| Report date | May 8, 2024 |
| Termination date | Apr 26, 2024 |
| City | Oklahoma City |
| State | OK |
| Country | United States |
| FEI number | 1626009 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: